Dr. Gloria Gaupmann
ROSA consult
Symposia
The EU Commission positively surprised the industry in spring 2024 by launching a counterpart to the US Biotech and Biomanufacturing Initiative. The EU Biotech Act is due to come in 2025. What can this act do for the industry? What should the Act encompass in order warrant that Europe stays competitive with biotechnology?
Dr. Gloria Gaupmann
ROSA consult
Hanna Freienstein
DG GROW
Prof. Dr. Andrea Wechsler
MEP, CDU